收藏切换
Research progress of histone deacetylases inhibitors in antiviral drugs discovery
收藏切换
PDF
Li XU, Nian-dong MAO, Hang ZHANG, Xing-rui HE*, Xiang-yang YE*, Tian XIE*
Acta Pharmaceutica Sinica | 2022, 57(4) : 917 - 930
Less
收藏切换
Acta Pharmaceutica Sinica | 2022, 57(4): 917-930
Reviews
Research progress of histone deacetylases inhibitors in antiviral drugs discovery
Full
Li XU, Nian-dong MAO, Hang ZHANG, Xing-rui HE*, Xiang-yang YE*, Tian XIE*
Affiliations
  • School of Pharmacy, Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou 311121, China
Published: 2022-04-12 doi: 10.16438/j.0513-4870.2021-1594
Outline
收藏切换

Histone deacetylases (HDACs) are a class of key enzymes that regulate epigenetics. There are 5 small-molecule HDACs inhibitors having been approved for anti-cancer therapy on the market. In recent years, there have been more and more studies on the antiviral aspects of HDACs inhibitors. This article classifies viruses into human immunodeficiency virus 1 (HIV-1), new coronavirus (SARS-CoV-2), Epstein-Barr virus (EBV) and other viruses, systematically summarizes the recent advances of antiviral effects of the HDACs inhibitors from the perspective of medicinal chemistry. This review aims to provide the researchers the convenience of accessing the latest advances of the antiviral effects of HDACs inhibitors, and to analyze the challenges and prospects of this field in future drug discovery.

histone deacetylases inhibitor  /  HIV-1  /  SARS-CoV-2  /  EBV
Li XU, Nian-dong MAO, Hang ZHANG, Xing-rui HE, Xiang-yang YE, Tian XIE. Research progress of histone deacetylases inhibitors in antiviral drugs discovery[J]. Acta Pharmaceutica Sinica, 2022 , 57 (4) : 917 -930 . DOI: 10.16438/j.0513-4870.2021-1594
Year 2022 volume 57 Issue 4
PDF
190
72
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2021-1594
  • Receive Date:2021-11-08
  • Online Date:2025-12-22
  • Published:2022-04-12
Article Data
Affiliations
History
  • Received:2021-11-08
  • Revised:2021-12-07
Funding
Affiliations
    School of Pharmacy, Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou 311121, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2021-1594
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT